ULIVELLI, MONICA
 Distribuzione geografica
Continente #
NA - Nord America 9.126
EU - Europa 7.415
AS - Asia 3.933
SA - Sud America 717
AF - Africa 286
OC - Oceania 18
Continente sconosciuto - Info sul continente non disponibili 12
Totale 21.507
Nazione #
US - Stati Uniti d'America 8.968
GB - Regno Unito 2.011
RU - Federazione Russa 1.352
SG - Singapore 1.331
CN - Cina 1.298
IT - Italia 998
IE - Irlanda 926
BR - Brasile 586
SE - Svezia 515
UA - Ucraina 450
FR - Francia 388
VN - Vietnam 333
DE - Germania 324
HK - Hong Kong 294
KR - Corea 182
FI - Finlandia 176
ZA - Sudafrica 135
IN - India 96
TR - Turchia 87
BD - Bangladesh 77
CA - Canada 71
ES - Italia 54
MX - Messico 53
NL - Olanda 52
AR - Argentina 45
CI - Costa d'Avorio 45
NG - Nigeria 45
IQ - Iraq 40
PL - Polonia 35
AT - Austria 31
BE - Belgio 24
SA - Arabia Saudita 24
PK - Pakistan 22
EC - Ecuador 21
JP - Giappone 21
VE - Venezuela 19
AU - Australia 16
CL - Cile 13
AE - Emirati Arabi Uniti 12
MA - Marocco 12
PH - Filippine 12
KE - Kenya 11
KZ - Kazakistan 11
CO - Colombia 10
UZ - Uzbekistan 10
DZ - Algeria 9
ID - Indonesia 9
PE - Perù 9
CH - Svizzera 8
CZ - Repubblica Ceca 8
JM - Giamaica 8
LB - Libano 8
LT - Lituania 8
MY - Malesia 8
NP - Nepal 8
RO - Romania 8
EU - Europa 7
GR - Grecia 7
IL - Israele 7
JO - Giordania 7
PY - Paraguay 7
AL - Albania 6
PA - Panama 6
SN - Senegal 6
TN - Tunisia 6
EG - Egitto 5
MN - Mongolia 5
OM - Oman 5
AZ - Azerbaigian 4
DO - Repubblica Dominicana 4
GE - Georgia 4
IR - Iran 4
LV - Lettonia 4
RS - Serbia 4
UY - Uruguay 4
BO - Bolivia 3
BS - Bahamas 3
CR - Costa Rica 3
DK - Danimarca 3
EE - Estonia 3
KG - Kirghizistan 3
LK - Sri Lanka 3
LU - Lussemburgo 3
NO - Norvegia 3
SI - Slovenia 3
SY - Repubblica araba siriana 3
TT - Trinidad e Tobago 3
XK - ???statistics.table.value.countryCode.XK??? 3
BG - Bulgaria 2
BW - Botswana 2
ET - Etiopia 2
GA - Gabon 2
GT - Guatemala 2
HU - Ungheria 2
NI - Nicaragua 2
PT - Portogallo 2
TH - Thailandia 2
A1 - Anonimo 1
A2 - ???statistics.table.value.countryCode.A2??? 1
AO - Angola 1
Totale 21.489
Città #
Southend 1.830
Fairfield 976
Dublin 914
Dallas 908
Ashburn 722
Singapore 675
Chandler 522
Santa Clara 476
Woodbridge 452
Wilmington 393
Jacksonville 367
Moscow 366
Houston 344
Cambridge 341
Seattle 340
Beijing 330
San Jose 299
Hong Kong 278
Ann Arbor 243
Hefei 232
Siena 202
Seoul 181
Princeton 159
The Dalles 154
Menlo Park 138
Johannesburg 127
Los Angeles 125
Milan 115
Nanjing 115
Council Bluffs 98
Ho Chi Minh City 95
New York 92
Lauterbourg 88
Helsinki 87
Florence 71
Hanoi 63
San Diego 63
Buffalo 62
Dong Ket 61
Munich 61
Boardman 60
San Mateo 55
São Paulo 55
Rome 52
Dearborn 50
Abidjan 45
Orem 45
Nanchang 44
Shanghai 44
Izmir 42
Abuja 40
London 39
Columbus 38
Norwalk 37
Tianjin 34
Málaga 31
Redondo Beach 31
San Francisco 29
Shenyang 27
Warsaw 27
Bengaluru 25
Brussels 24
Nuremberg 24
Jinan 23
Amsterdam 22
Changsha 21
Chicago 21
Frankfurt am Main 21
Rio de Janeiro 21
Triggiano 20
Vienna 20
Mexico City 19
Toronto 19
Belo Horizonte 18
Fremont 18
Brooklyn 17
Denver 17
Guangzhou 17
Tokyo 17
Turku 17
Düsseldorf 16
Stockholm 16
Ankara 15
Kunming 15
Lappeenranta 15
Boston 14
Chennai 14
Da Nang 14
Ottawa 14
Washington 14
Atlanta 13
Montreal 13
Zhengzhou 13
Baghdad 12
Charlotte 12
Haiphong 12
Jiaxing 12
Hangzhou 11
Hebei 11
North Bergen 11
Totale 14.658
Nome #
Incidenza della sclerosi multipla in Toscana: uno studio basato su dati amministrativi 462
Which patients discontinue? Issues on Levodopa/carbidopa intestinal gel treatment: Italian multicentre survey of 905 patients with long-term follow-up 326
A mimic of first dorsal interosseus atrophy revealed by ultrasound study 313
Relevance of cognitive deterioration in early relapsing-remitting MS: a 3-year follow-up study 299
Multiple sclerosis incidence in Tuscany from administrative data 298
Cross-Modal Audiovisual Modulation of Corticospinal Motor Synergies in Professional Piano Players: A TMS Study during Motor Imagery 294
Dysfunctions of cortical excitability in drug-naïve posttraumatic stress disorder patients 291
Homocysteinemia control by cysteine in cerebral vascular patients after methionine loading test: evidences in physiological and pathological conditions in cerebro-vascular and multiple sclerosis patients 272
Multiple sclerosis spatial cluster in Tuscany 272
Multiple sclerosis incidence in Tuscany from administrative data 264
Individual factors enhance poor health-related quality of life outcome in multiple sclerosis patients. Significance of predictive determinants 263
Incidenza della sclerosi multipla in Toscana: uno studio basato sui dati amministrativi 255
Citalopram as treatment of depression in patients with epilepsy 254
Relevance of 4-F4t-neuroprostane and 10-F4t-neuroprostane to neurological diseases 251
A clinically silent, but severe, duodenal complication of duodopa infusion 250
COVID-19 Severity in Multiple Sclerosis: Putting Data Into Context 250
Polysomnographic characterization of pergolide-induced sleep attacks in idiopathic PD. 249
Complessità terapeutico-assistenziale e management della sclerosi multipla: utilizzo di indicatori basati sul dato amministrativo 245
Reliability, practice effects, and change indices for Rao's Brief Repeatable Battery. 245
A real electro-magnetic placebo (REMP) device for sham transcranial magnetic stimulation (TMS) 242
Prevalence of multiple sclerosis in tuscany (central Italy): a study based on validated administrative data 241
The Italian Multiple Sclerosis Register 239
Increasing prevalence of multiple sclerosis in Tuscany, Italy 238
The control of hyperhomocysteinemia through thiol exchange mechanisms by mesna 236
Anhedonia and cognitive impairment in Parkinson's disease: Italian validation of the Snaith-Hamilton Pleasure Scale and its application in the clinical routine practice during the PRIAMO study 236
Clinical evidence of fluconazole-induced carbamazepine toxicity 234
Incidenza della sclerosi multipla in Toscana: uno studio basato su dati amministrativi 234
CAT and MRI in the study of partial epilepsy: comparison of the 2 methods and correlations with EEG [TAC e RMN nello studio delle epilessie parziali: confronto tra le due metodiche e correlazioni con l'EEG] 233
Carbamazepine and carbamazepine-epoxide plasma levels during lamotrigine add-on [Livelli plasmatici di carbamazepina e carbamazepina epossido dopo add-on di lamotrigina] 231
Mortality trend for multiple sclerosis in Italy during the period 1980–2015 231
Non-motor symptoms in atypical and secondary parkinsonism: the PRIAMO study. 228
Antiparkinsonian drugs and visual hallucinations 228
Neurophysiological Correlates of Central Fatigue in Healthy Subjects and Multiple Sclerosis Patients before and after Treatment with Amantadine 228
Prevalence of multiple sclerosis in Tuscany at 2011: a study based on validated administrative data 228
Breakthrough SARS-CoV-2 infections in MS patients on disease-modifying therapies 227
Hypofunctioning of sensory gating mechanisms in patients with obsessive-compulsive disorder. 224
Increasing prevalence of multiple sclerosis in Tuscany: a study based on validated administrative data 224
Jitter of corticospinal neurons during repetitive transcranial magnetic stimulation. Method and possible clinical implications 223
Association of celiac disease in patients with multiple sclerosis in Tuscany 223
La distribuzione geografica della sclerosi multipla in Toscana 222
Effects of repetitive transcranial magnetic stimulation on chronic tinnitus: a randomised, crossover, double blind, placebo controlled study 221
The influence of diabetes and hyperglycemia on clinical course after intracerebral hemorrhage. 218
Breakthrough SARS-CoV-2 infections after COVID-19 mRNA vaccination in MS patients on disease modifying therapies during the Delta and the Omicron waves in Italy 213
Distinct olfactory cross-modal effects on the human motor system 213
Antibody response elicited by the SARS-CoV-2 vaccine booster in patients with multiple sclerosis: Who gains from it? 206
Increasing prevalence of multiple sclerosis in Tuscany: a study based on validated administrative data 206
Emerging of new bioartificial corticospinal motor synergies using a robotic additional thumb 205
Effects of repetitive transcranial magnetic stimulation on movement-related cortical activity in humans 203
Prevalence of multiple sclerosis in Tuscany: a study based on administrative data 202
Clinical and MRI measures to identify non-acute MOG-antibody disease in adults 200
Somatosensory evoked potentials reflect the upper limb motor performance in multiple sclerosis. 199
Detection of disability worsening in relapsing-remitting multiple sclerosis patients: a real-world roving Expanded Disability Status Scale reference analysis from the Italian Multiple Sclerosis Register 198
Early somatosensory processing during tonic muscle pain in humans: relation to loss of proprioception and motor 'defensive' strategies 197
Wearable haptic anklets for gait and freezing improvement in Parkinson’s disease: a proof-of-concept study 197
Multicenter case-control study on restless legs syndrome in multiple sclerosis: the REMS study 195
Reliability of administrative data for the identification of Parkinson's disease cohorts 195
The heart side of brain neuromodulation 195
Observational case-control study of the prevalence of chronic cerebrospinal venous insufficiency in multiple sclerosis: results from the CoSMo study 194
Imaging of the dopamine transporter predicts pattern of disease progression and response to levodopa in patients with schizophrenia and parkinsonism: a 2-year follow-up multicenter study 191
Repetitive transcranial magnetic stimulation (rTMS) in the treatment of obsessive-compulsive disorder (OCD) and Tourette's syndrome (TS) 189
The PRIAMO study: A multicenter assessment of nonmotor symptoms and their impact on quality of life in Parkinson's disease 185
Feasibility of TMS in patients with new generation cochlear implants 185
SARS-CoV-2 serology after COVID-19 in multiple sclerosis: An international cohort study 185
Mortality of Alzheimer’s disease in Italy from 1980 to 2015 184
The olfactory side of Parkinson disease: Relevance for clinical practice 184
Safety of the first dose of fingolimod for multiple sclerosis: Results of an open-label clinical trial 184
Primary intraventricular haemorrhage in adults 184
Effects of immunotherapy on motor cortex excitability in Stiff Person Syndrome 180
Reply to "Motor assessment of upper extremity function and its relation with fatigue, cognitive function and quality of life in multiple sclerosis patients" 180
Seizures after spontaneous supratentorial intracerebral hemorrhage 180
Effects of rehabilitation treatment of the upper limb in multiple sclerosis patients and predictive value of neurophysiological measures 180
Repetitive Transcranial Magnetic Stimulation (rTMS) in the treatment of panic disorder (PD) with comorbid major depression 179
Regulation of redox forms of plasma thiols by albumin in multiple sclerosis after fasting and methionine loading test 178
Effect of SARS-CoV-2 mRNA vaccination in MS patients treated with disease modifying therapies 178
Somatosensory processing during movement observation in humans 177
Access to social security benefits among multiple sclerosis patients in Italy: A cross-sectional study 176
Human herpesvirus-6B active infection associated with relapsing bilateral anterior optic neuritis 175
Mortality of Parkinson’s disease in Italy from 1980 to 2015 175
Quantitative ColourDopplerSonography evaluation of cerebral venous outflow: a comparative study between patients with multiple sclerosis and controls 173
The PRIAMO study: age- and sex-related relationship between prodromal constipation and disease phenotype in early Parkinson’s disease 173
Modulation of high-frequency (600 Hz) somatosensory-evoked potentials after rTMS of the primary sensory cortex 172
Slow repetitive TMS for drug-resistant epilepsy: clinical and EEG findings of a placebo-controlled trial 172
Suprathreshold 0.3 Hz repetitive TMS prolongs the cortical silent period: potential implications for therapeutic trials in epilepsy 170
DMTs and Covid-19 severity in MS: a pooled analysis from Italy and France 170
rTMS for PTSD: induced merciful oblivion or elimination of abnormal hypermnesia? 164
Temporal dynamics of memory trace formation in the human prefrontal cortex 163
Frequency of the LRRK2 G2019S mutation in Italian patients affected by Parkinson's disease 160
Reduction of cortical myoclonus-related epileptic activity following slow-frequency rTMS 157
Quantitative analysis of Lamotrigine in plasma and tablets by planar chromatography and comparison with liquid 153
Signs and symptoms of Covid‐19 in patients with multiple sclerosis 144
Prospective study of clinical, neurophysiological and urodynamic findings in multiple scleosis patients undergoing percutaneous transluminal venous angioplasty 144
The role of ethnicity and native-country income in multiple sclerosis: the Italian multicentre study (MS-MigIT) 137
Uveitis: A snapshot in the MOG antibody spectrum 137
Prevalence and impact of COVID-19 in Parkinson’s disease: evidence from a multi-center survey in Tuscany region 134
The impact of PM2.5, PM10 and NO2 on Covid-19 severity in a sample of patients with multiple sclerosis: A case-control study 132
Human ventral parietal cortex plays a functional role on visuospatial attention and primary consciousness. A repetitive transcranial magnetic stimulation study 131
Pisa syndrome in Parkinson disease 131
Krebs von den Lungen-6 (KL-6) in cerebrospinal fluid from neurosarcoidosis patients 128
Grey Matter Atrophy and its Relationship with White Matter Lesions in Patients with Myelin Oligodendrocyte Glycoprotein Antibody-associated Disease, Aquaporin-4 Antibody-Positive Neuromyelitis Optica Spectrum Disorder, and Multiple Sclerosis 127
Does Risk of Hyperhomocysteinemia Depend on Thiol-Disulfide Exchange Reactions of Albumin and Homocysteine? 125
Totale 20.786
Categoria #
all - tutte 66.862
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 66.862


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021178 0 0 0 0 0 0 0 0 0 0 0 178
2021/20221.480 97 179 106 89 141 70 78 52 100 143 152 273
2022/20231.943 114 191 280 250 163 369 52 177 192 48 70 37
2023/20241.408 64 27 116 82 42 362 485 55 13 21 43 98
2024/20253.083 57 163 271 174 399 182 148 196 282 122 333 756
2025/20266.841 505 940 772 770 1.226 285 783 281 289 441 327 222
Totale 21.815